mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
0.0006 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.21 |
0.001 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |